{
    "@context": "http://schema.org/",
    "@type": "Dataset",
    "_id": "vivli_e120e4d1-d2b8-4f0d-972c-734a5676fbfc",
    "_ignored": [
        "all.keyword"
    ],
    "_score": 9.076288,
    "author": {
        "name": "BioLINCC (a data-sharing platform funded by the National Institutes of Health)"
    },
    "conditionsOfAccess": "Restricted",
    "creator": [
        {
            "@type": "Person",
            "affiliation": [
                {
                    "@type": "Organization",
                    "name": "The University of Texas Health Science Center, Houston"
                }
            ],
            "name": "Barry R Davis",
            "role": "PRINCIPAL_INVESTIGATOR",
            "title": "Professor of Biostatistics"
        },
        {
            "@type": "Person",
            "affiliation": [
                {
                    "@type": "Organization",
                    "name": "CCTRN Steering Committee Chair"
                }
            ],
            "name": "Robert Simari, MD",
            "role": "STUDY_CHAIR"
        }
    ],
    "date": "2025-02-06",
    "dateCreated": "2022-11-16",
    "dateModified": "2025-02-06",
    "datePublished": "2022-12-07",
    "description": "The primary purpose of this study is to examine the safety and feasibility of delivering\r allogeneic human mesenchymal stem cells (allo-MSCs) by transendocardial injection to cancer\r survivors with left ventricular (LV) dysfunction secondary to anthracycline-induced\r cardiomyopathy (AIC).\r\r The secondary purpose of this study is to obtain preliminary evidence for therapeutic\r efficacy of allo-MSCs delivered by transendocardial injection to cancer survivors with LV\r dysfunction secondary to AIC.",
    "doi": "https://doi.org/10.25934/PR00008647",
    "funding": [
        {
            "funder": {
                "@type": "Organization",
                "name": "The University of Texas Health Science Center, Houston"
            }
        },
        {
            "funder": {
                "@type": "Organization",
                "alternateName": [
                    "NIH/National Heart, Lung and Blood Institute",
                    "National Heart Lung & Blood Institute",
                    "NHLBI"
                ],
                "identifier": "https://ror.org/012pb6c26",
                "name": "National Heart, Lung, and Blood Institute",
                "parentOrganization": "National Institutes of Health"
            }
        }
    ],
    "identifier": [
        "NCT02509156",
        "5UM1HL087318"
    ],
    "includedInDataCatalog": {
        "@type": "DataCatalog",
        "archivedAt": "https://doi.org/10.25934/PR00008647",
        "name": "Vivli",
        "url": "https://vivli.org/",
        "versionDate": "2025-08-16"
    },
    "isAccessibleForFree": true,
    "keywords": [
        "Interventional",
        "Pharmacological Interventions",
        "Injection",
        "Allogeneic Adipose Tissue-derived Mesenchymal Stem Cells ",
        "Male and Female",
        "Young Adult 19-24 years",
        "Aged 65-79 years",
        "Adolescent 13-18 years",
        "Phase1"
    ],
    "measurementTechnique": [
        {
            "@type": "DefinedTerm",
            "fromNCT": true,
            "identifier": "C82639",
            "inDefinedTermSet": "NCIT",
            "isCurated": false,
            "name": "Parallel Study",
            "url": "http://purl.obolibrary.org/obo/NCIT_C82639"
        },
        {
            "@type": "DefinedTerm",
            "fromNCT": true,
            "identifier": "C15417",
            "inDefinedTermSet": "NCIT",
            "isCurated": false,
            "name": "Randomized Clinical Trial",
            "url": "http://purl.obolibrary.org/obo/NCIT_C15417"
        },
        {
            "@type": "DefinedTerm",
            "fromNCT": true,
            "identifier": "C70840",
            "inDefinedTermSet": "NCIT",
            "isCurated": false,
            "name": "Blinded Clinical Study",
            "url": "http://purl.obolibrary.org/obo/NCIT_C70840"
        }
    ],
    "name": "Dataset from A Phase I, First-in-Human, Multicenter, Randomized, Double-Blinded, Placebo-Controlled Study of the Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Cancer Survivors With Anthracycline-Induced Cardiomyopathy",
    "nctid": "NCT02509156",
    "sdPublisher": [
        {
            "identifier": "NCT02509156",
            "name": "ClinicalTrials.gov"
        }
    ],
    "spatialCoverage": [
        {
            "identifier": "USA",
            "name": "United States"
        }
    ],
    "species": [
        {
            "alternateName": [
                "Humo sapiens",
                "Home sapiens",
                "Homo sapines",
                "Homo sapian",
                "Homo sapiens Linnaeus, 1758",
                "Homo sampiens",
                "Homo sapians",
                "Homo sapien",
                "Homo sapients",
                "Homo spaiens",
                "Homo spiens",
                "Human",
                "Homo sapeins",
                "Homo sapience",
                "Homo sapiense",
                "human"
            ],
            "classification": "host",
            "commonName": "Human",
            "displayName": "Human | Homo sapiens",
            "fromEXTRACT": true,
            "identifier": "9606",
            "inDefinedTermSet": "UniProt",
            "isCurated": false,
            "name": "Homo sapiens",
            "originalName": "human",
            "url": "https://www.uniprot.org/taxonomy/9606"
        }
    ],
    "temporalCoverage": {
        "temporalInterval": {
            "endDate": "2020-04-20",
            "startDate": "2016-08-01"
        }
    },
    "topicCategory": [
        {
            "@type": "DefinedTerm",
            "curatedBy": {
                "name": "GPT-4o-mini",
                "url": "https://openai.com/index/chatgpt"
            },
            "fromGPT": true,
            "identifier": "topic_2640",
            "inDefinedTermSet": "EDAM",
            "name": "Oncology",
            "url": "http://edamontology.org/topic_2640"
        },
        {
            "@type": "DefinedTerm",
            "curatedBy": {
                "name": "GPT-4o-mini",
                "url": "https://openai.com/index/chatgpt"
            },
            "fromGPT": true,
            "identifier": "topic_3335",
            "inDefinedTermSet": "EDAM",
            "name": "Cardiology",
            "url": "http://edamontology.org/topic_3335"
        },
        {
            "@type": "DefinedTerm",
            "curatedBy": {
                "name": "GPT-4o-mini",
                "url": "https://openai.com/index/chatgpt"
            },
            "fromGPT": true,
            "identifier": "topic_3373",
            "inDefinedTermSet": "EDAM",
            "name": "Drug development",
            "url": "http://edamontology.org/topic_3373"
        }
    ],
    "url": "https://doi.org/10.25934/PR00008647",
    "variableMeasured": [
        {
            "name": [
                "Stroke",
                "Myocardial Infarction",
                "Cardiac Tamponade",
                "Hypersensitivity Reaction",
                "Neoplastic Disease",
                "Left Ventricular Ejection Fraction",
                "Left Ventricular Ejection Fraction",
                "Magnetic Resonance Imaging",
                "Magnetic Resonance Imaging",
                "Magnetic Resonance Imaging",
                "Magnetic Resonance Imaging",
                "Assessment Of Quality Of Life",
                "Assessment Of Quality Of Life"
            ]
        }
    ]
}